Home  /  Resource Library  /  Health related quality of life with fixed duration venetoclax obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial

Health related quality of life with fixed duration venetoclax obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial

Results of a study measuring health related quality of life outcomes in patients with CLL treated with venetoclax combined with obinutuzumab.